DRKS00020130
Recruiting
N/A
Early Prostate cancer recurrence with PSMA PET positive unilateral pelvic lesion(s): is one-sided salvage extended lymph node dissection enough? - ProSTone Study
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- C61
- Sponsor
- Martini-Klinik am UKE GmbH
- Enrollment
- 397
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients in good general condition with life expectancy\> 10 years
- •Hormone\-sensitive prostate cancer recurrence after radical prostatectomy (patients with status post salvage prostatectomy may be included; salvage radiotherapy for prostate fossa and / or pelvic lymph drainage after radical prostatectomy is not an exclusion criterion)
- •Unilateral detection of \= 3 PSMA PET positive lymph node metastases in the pelvis (up ot origin of the inferior mesenteric artery)
- •PSA at the time of PSMA PET imaging \<4 ng / ml
Exclusion Criteria
- •Contraindication for surgery or bilateral salvage lymph node dissection
- •Suspected prostate cancer recurrence in the prostate fossa (local recurrence) or extrapelvic metastasis on PSMA PET imaging
- •Date of PSMA PET examination \> 4 months prior to salvage lymph node dissection
- •Hormone therapy within 6 months prior to study enrollment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
PSMA PET prostate cancer registration studyProstate cancerNL-OMON28640-
Completed
N/A
PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical TreatmentProstatic NeoplasmsNCT04298112Norwegian University of Science and Technology300
Active, Not Recruiting
Phase 1
PSMA-PET/CT for prostate cancerEUCTR2017-003461-96-BEGhent University Hospital72
Active, Not Recruiting
Phase 1
Staging patients with newly diagnosed prostate cancer: A clinical trial comparing traditional scan types with an up-to-date specific scan type.EUCTR2021-000123-12-DKOdense University Hospital448
Active, Not Recruiting
Phase 1
Comparison of three methosd to identify prostate cancer relapse in patient who precviously have been through curative intended threapyEUCTR2014-005073-37-DKDepartment of Nuclear Medicine, Aalborg University Hospital